![Martin Jerndal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Jerndal
Geen lopende functies
Profiel
Martin Jerndal formerly worked at Scandinavian ChemoTech AB, as Director from 2015 to 2019 and Nordea Markets, as Head-Credit Trading & Complex Risk from 2004 to 2017.
Mr. Jerndal received his graduate degree from the University of Lund.
Eerdere bekende functies van Martin Jerndal
| Bedrijven | Functie | Einde |
|---|---|---|
| SCANDINAVIAN CHEMOTECH AB | Directeur/Bestuurslid | 01-06-2019 |
Nordea Markets
 Nordea Markets Financial ConglomeratesFinance Provides financial and investment services | Corporate Officer/Principal | 01-01-2017 |
Opleiding van Martin Jerndal
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
2
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nordea Markets
Nordea Markets Financial ConglomeratesFinance Provides financial and investment services | Finance |
Scandinavian ChemoTech AB
 Scandinavian ChemoTech AB Medical SpecialtiesHealth Technology Provides cancer treatment and pain management services | Health Technology |
